Defyrus

Defyrus is a life sciences company focused on developing innovative countermeasures against infectious diseases and biological threats. The company specializes in the development of broad-spectrum anti-infectives and vaccines, utilizing advanced platforms to address high-priority pathogens such as Ebola, Anthrax, and Influenza. Defyrus has established significant collaborations with government agencies, including the U.S. Department of Defense and Public Health Agency of Canada, to advance its pipeline of biodefense and public health products. Their lead programs include novel monoclonal antibodies and viral vector-based vaccines designed for rapid response and high efficacy in emergency settings.